Ashton Thomas Private Wealth’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,448
| Closed | -$226K | – | 998 |
|
|
2024
Q2 | $226K | Buy |
2,448
+40
| +2% | +$3.7K | 0.01% | 538 |
|
|
2024
Q1 | $230K | Sell |
2,408
-758
| -24% | -$72.4K | 0.01% | 552 |
|
|
2023
Q4 | $241K | Sell |
3,166
-2,056
| -39% | -$157K | 0.02% | 529 |
|
|
2023
Q3 | $362K | Buy |
5,222
+2,470
| +90% | +$171K | 0.03% | 452 |
|
|
2023
Q2 | $260K | Sell |
2,752
-97
| -3% | -$9.15K | 0.02% | 509 |
|
|
2023
Q1 | $236K | Buy |
2,849
+163
| +6% | +$13.5K | 0.02% | 455 |
|
|
2022
Q4 | $200K | Sell |
2,686
-309
| -10% | -$23.1K | 0.02% | 457 |
|
|
2022
Q3 | $247K | Buy |
2,995
+6
| +0.2% | +$496 | 0.03% | 414 |
|
|
2022
Q2 | $284K | Sell |
2,989
-4,653
| -61% | -$442K | 0.03% | 384 |
|
|
2022
Q1 | $900K | Sell |
7,642
-219
| -3% | -$25.8K | 0.08% | 264 |
|
|
2021
Q4 | $1.02M | Buy |
7,861
+591
| +8% | +$76.6K | 0.1% | 232 |
|
|
2021
Q3 | $823K | Buy |
7,270
+673
| +10% | +$76.2K | 0.12% | 191 |
|
|
2021
Q2 | $683K | Sell |
6,597
-2,866
| -30% | -$297K | 0.1% | 216 |
|
|
2021
Q1 | $791K | Sell |
9,463
-936
| -9% | -$78.3K | 0.13% | 180 |
|
|
2020
Q4 | $949K | Buy |
10,399
+2,240
| +27% | +$204K | 0.18% | 155 |
|
|
2020
Q3 | $651K | Buy |
8,159
+4,297
| +111% | +$343K | 0.16% | 152 |
|
|
2020
Q2 | $267K | Buy |
+3,862
| New | +$267K | 0.08% | 200 |
|